These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11073267)

  • 21. Pathogenesis and medical treatment of secondary hyperparathyroidism.
    Fukagawa M; Kurokawa K
    Semin Surg Oncol; 1997; 13(2):73-7. PubMed ID: 9088062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating parathyroid hormone concentration in chronic renal insufficiency.
    Reiss E; Canterbury JM; Kanter A
    Arch Intern Med; 1969 Oct; 124(4):417-22. PubMed ID: 5823012
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulation of the parathyroid hormone gene by calcium, phosphate and 1,25-dihydroxyvitamin D.
    Silver J; Moallem E; Kilav R; Sela A; Naveh-Many T
    Nephrol Dial Transplant; 1998; 13 Suppl 1():40-4. PubMed ID: 9507497
    [No Abstract]   [Full Text] [Related]  

  • 24. Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects.
    Llach F; Velasquez Forero F
    Am J Kidney Dis; 2001 Nov; 38(5 Suppl 5):S20-33. PubMed ID: 11689384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary hyperparathyroidism in chronic renal disease.
    Potts JT; Reita RE; Deftos LJ; Kaye MB; Richardson JA; Buckle RM; Aurbach GD
    Arch Intern Med; 1969 Oct; 124(4):408-12. PubMed ID: 5387817
    [No Abstract]   [Full Text] [Related]  

  • 26. Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure.
    Martín-Salvago M; Villar-Rodríguez JL; Palma-Alvarez A; Beato-Moreno A; Galera-Davidson H
    Endocr Pathol; 2003; 14(1):61-70. PubMed ID: 12746564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary hyperparathyroidism in chronic renal failure.
    Wills MR; Savory J
    Ann Clin Lab Sci; 1981; 11(3):252-61. PubMed ID: 6264838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased parathyroid expression of klotho in uremic rats.
    Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
    Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism.
    Slatopolsky E; Brown A; Dusso A
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S54-7. PubMed ID: 11158862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcription factor MafB may play an important role in secondary hyperparathyroidism.
    Morito N; Yoh K; Usui T; Oishi H; Ojima M; Fujita A; Koshida R; Shawki HH; Hamada M; Muratani M; Yamagata K; Takahashi S
    Kidney Int; 2018 Jan; 93(1):54-68. PubMed ID: 28964572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Has parathyroid hormone any influence on lipid metabolism in chronic renal failure?
    Arnadottir M; Nilsson-Ehle P
    Nephrol Dial Transplant; 1995 Dec; 10(12):2381-2. PubMed ID: 8808260
    [No Abstract]   [Full Text] [Related]  

  • 32. Proliferation of parathyroid cells negatively correlates with expression of parathyroid hormone-related protein in secondary parathyroid hyperplasia.
    Matsushita H; Hara M; Endo Y; Shishiba Y; Hara S; Ubara Y; Nakazawa H; Suzuki N; Kawaminami K; Kido T; Li Q; Grimelius L
    Kidney Int; 1999 Jan; 55(1):130-8. PubMed ID: 9893121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve.
    Bas S; Aguilera-Tejero E; Bas A; Estepa JC; Lopez I; Madueño JA; Rodriguez M
    J Endocrinol; 2005 Jan; 184(1):241-7. PubMed ID: 15642800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics.
    Goodman WG; Quarles LD
    Kidney Int; 2008 Aug; 74(3):276-88. PubMed ID: 17568787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New insights in the pathogenesis of secondary hyperparathyroidism].
    Cozzolino M; Butti A; Chiarelli G; Rocca-Rey L; Bellasi A; Galassi A; Gallieni M; Brancaccio D
    G Ital Nefrol; 2005; 22(4):329-36. PubMed ID: 16267793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid dysfunction end stage renal disease.
    DiTella PJ; Lang GR
    Otolaryngol Clin North Am; 1980 Feb; 13(1):193-201. PubMed ID: 7367004
    [No Abstract]   [Full Text] [Related]  

  • 37. [Parathyroid hormone and calcitonin in chronic kidney failure].
    Okazaki R; Matsumoto T
    Nihon Rinsho; 1992 Jan; 50 Suppl():600-5. PubMed ID: 1578744
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus.
    Yi H; Fukagawa M; Yamato H; Kumagai M; Watanabe T; Kurokawa K
    Nephron; 1995; 70(2):242-8. PubMed ID: 7566311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperparathyroidism and parathyroidectomy in renal failure.
    Kaye M
    Int J Artif Organs; 1990 Dec; 13(12):787-9. PubMed ID: 2289829
    [No Abstract]   [Full Text] [Related]  

  • 40. Parathyroid growth and suppression in renal failure.
    Lewin E; Huan J; Olgaard K
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.